The list of Ca2+ channels involved in stimulus-secretion coupling in p-cells is increasing. In this respect the roles of the voltage-gated Ca2+ channels and IP, receptors are well accepted. There is a lack of consensus about the significance of a third group of c a 2 + channels called ryanodine (RYJ receptors. These are large conduits located on Ca 
determined by Ca2+ fluxes through several Ca2' channels as well as a dynamic interplay between multiple Ca2+-handling systems and signaling molecules (I). In this respect the intracellular c a 2 + pools of p-cells play critical roles. Recent studies demonstrate that these Ca" pools participate in amplification of Ca2+ signaling (2) . ~a " fluxes across these Ca2+ pools regulate plasma membrane ionic events and thereby ensure rhythmic changes in membrane potential, [Cast] ,, and pulsatile insulin secretion (3,4).
Glucose-stimulated [Ca2+], increase in p-cells requires C2+ entry through ~a " + channels that are gated by voltage.
These channels are located on the plasma membrane and are thus easy to study by the patch-clamp teclmique. Located deeper inside the cell, and thus more difficult to study, are two other groups of ca2+ channels that are gated by ~2 + rather than by voltage. The names of these channels, IP, receptor (IP,R) and ryanodme (RY) receptor, do not underscore their &+ channel function or their gating mechanism.
RY receptors are so named because a plant alkaloid ryanodme binds to these channels with nanomolar affinity. These are huge conduits for Ca2+ release, abundant in muscle cells and some neurons. There is now considerable evidence that such channels are present in p-cells too (5) . A critical property of RY receptors is that cytosolic Ca2+ can activate these channels. In principle, such c$+-induced ca2+ release (CICR) can provide a mechanism for amplification of Ca'+ signals elicited by voltage-gated Ca2+ channels or the IP,Rs. IIowever, despite a decade of study, there is still no consensus among islet researchers on the role of RY receptors in stimulus-secretion coupling, and some investigators even doubt that such channels are present in p-cells.
I shall outline what we have learned so far about the significance of RY receptors in p-cells and discuss open issues that require more research. I shall briefly describe some distinct properties of the RY receptors and the usage of relevant pharn~acological tools to illustrate potential difficulties involved in studying these channels. Finally, I shall highlight some properties of these channels that are attractive from the viewpoint of stimulus-secretion coupling. I shall try to strike a balance between caution against over-interpretation and anticipation of the direction in which the field may head. invertebrates. The phylogenetic tree of RY receptor family suggests that the three vertebrate RY receptor genes were probably generated at the same time (7) . However, one analysis suggests that RY, may be the original vertebrate form of RY receptors (8) . The three isoforms probably arose by two gene duplication events in vertebrates (9) . Discovery of RY receptor of P-cells. Investigators considered the possibility that p-cells might have RY receptorlike channels when they found that theophylline releases ca2+ from intracellular stores (10) . After the discovery that IP, releases ca2+ from the endoplasmic reticulum (ER) of p-cells, studies of this channel dominated the field (11) . However, IP, can release only -50% of the ca2+ sequestered into the ER (11) . It was a possibility that the IPS-insensitive ER Ca2+ pool may be equipped with the RY receptor (5). Thimerosal, a sulfhydryl-oxidizing agent that activates RY receptors, proved useful to test this hypothesis. In RINm5F cells and p-cells obtained from ob/ob mice, thimerosal released Ca2+ from the 1P3-insensitive ER ca2+ pool (5, 12) . The release was potentiated by caffeine, suggesting that a RY receptor might be involved. While thimerosal can activate some IP,Rs, the type 3 IP,R that is the predominant isoform in RINm5F cell and rat p-cells (13) is not activated by thimerosal (14) . Subsequent studies that demonstrated ca2+ release by ryanodine from islet microsomes (15) and by caffeine from ER of intact p-cells (16) strengthened the view that RY receptors are present in P-cell. Accumulating evidence for RY receptors in p-cells. RY receptors have been demonstrated in a variety of insulin-secreting cells (Table 1) . Such studies used pharmacological tools (5), endogenous ligands (15, 17) , molecular techniques (16, 18, 19) , and quantitative ryanodine-binding (19) . Some studies, however, imply total lack of RY receptors in p-cells (20, 211 . Contradictory reports as to whether p-cells have RY receptors are common even when the same investigators are involved (16, 20, 22, 23) . This may be due to low abundance of these channels, differences in cell types, or methods used. Thus, some clones of RINm5F cells have RY receptors (5,24) whereas others do not (25) . p-Cells from some colonies of ob/ob mice have RY receptors (16) whereas others do not (18) . When the same cell types are used, caffeine is more likely to release ca2& from the ER of intact cells (25, 26) than of penneabilized cells (231, suggesting that the permeabilization results in the loss of one or more regulatory factors.
The most abundant RY receptor mRNA in p-cells is that of RY,, as indicated by RNAse protection assay and RT-PCR analysis (16, 18, 19) . The probes and primers used in these studies target different regions of RY, cDNA that code for the highly conserved membrane-spanning and COOH-terminus~okions of RY,. It is not known whether the p-cell IEY, mRNA is identical to that of the heart or to one of its alternatively spliced transcripts. At the protein level, the presence of RY, receptors has been demonstrated by Western blot of membranes from INS-1 cells (25) . In human p-cells, the receptor has been demonstrated by quantitative ryanodine-binding (19) . Very low levels of RY, mRNA have been observed in PTC3 cells, and RY3 mRNA is expressed in HIT-TI5 cells (27) . Thus, on the balance of' current evidence, the existence of RY receptors in p-cells appears to be well documented. RY receptor density in p-cells. An (25, 26) .
In ob/ob mice, leptin deficiency leads to profound disturbances with accompanying changes in the islets. These mice are used as a model for studies in obesity and diabetes. Paradoxically, islets from ob/ob mice are used for "physiological" studies. This is because ob/ob islets are large and consist of 90-95% p-cells. These p-cells respond "normally" to elevated glucose with a release of insulin. However, islet-phenotype in these mice depends on the genetic background on which the ob gene is expressed. Islets from a noninbred colony of ob/ob mice express RY, at low level (16) . In islets of ob/ob mice obtained from the Jackson Laboratories (an inbred colony), RY, message was not detected even on PCR amplification (18) . Thus, the level of RY receptors in different strains of ob/ob mice varies. This may be one reason why cafieine and ryanodine are either not effective (21) or only marginally effective (20) in ob/ob p-cells. One study compared the levels of IP3Rs and RY receptors in mouse islets and concluded that mouse islets contain only RY, and almost no IP,Rs. However, these authors did not use efficient primers for IP3R-1, as they did not detect IP3R-1 mRNA in the brain (18) .
The relative densities of RY receptors and IP,Rs in p-cells may vary in different species. However, evidence that human p-cells have RY receptors is convincing (19) . Finally, it must be remembered that there is often no direct relationship between channel densities and the magnitude of a functional response. Thus, despite relatively low densities, strategic location of these channels at intracellular sites may be important for cell function.
STRUCTURES AND PROPERTIES OF RY RECEPTORS
Molecular make-up of RY receptors. RY receptors are made of four -560-kDa RY receptor protonlers and four associated molecules of FKBP12 or FKBP12.6 (31) . The latter are isoforms of the 12-kDa binding protein for the drug FK506. Each subunit of the RY receptor may form a pore and FKBP enables the four subunits to gate as one unit. The channel is a macromolecular complex with >20 associated proteins including calmodulin, calsequestrin, anchoring proteins, kinases, and phosphatases. The subunits of RY receptor have an enormous NH,-terminal cytosolic domain followed by 4-10 highly conserved transmembrane segments, which are followed by another short cytosolic domain. Cryoelectron microscopy and 3~-reconstruction reveal that RY receptor is a fourfold symmetrical mushroom-Iike structure with a large cytosolic assembly and a short transmembrane region. The cytosolic domain is the modulatory region and contains binding sites for Ca2', adenine nucleotides, calmodulin, FKBPs as well as the phosphorylation sites.
FKSOG-binding protein and RY receptor. FKBP12.6
binds to isoleucine-proline sequence of each subunit of RY, receptors and thereby stabilizes the RY receptor tetramer and facilitates coordinated gating of the channel. Immunosuppressants used in islet transplantation, e.g., sirolimus (rapamycin) and tacrolimus (FK506), bind to FKBP12.6. Islets contain FKBP12.6 and FKSO6 releases ca2+ from islet microsomes. According to one report, cADPR activates RY receptor by binding to FKBP12.6, but this view is not supported by other studies (32, 33) .
Basic molecular properties of RY receptors. RY receptor is a cation-selective channel that allows permeation of ca2+, many other divalent and monovalent cations, and under certain experimental conditions, even large molecules like glucose (34). Because of its short and wide channel region, RY receptor is suitable for sudden and large release of ca2+ from intracellular stores. Ca2+ conductance of RY receptor is on the order of 100 pS, which compares to about 10 pS for voltage-gated ca2' channels.
Physiological regulators of RY receptors include ~a " + , ~g , + , and ATP, which act by binding to the cytosolic sites. An important property of RY receptors is that they are regulated by ER Ca2+ load: the open probability of RY receptor is reduced as the luminal [Ca2+] is reduced. Ca2+ may be released spontaneously and cyclically when the ER Ca2+ load is high 35-37).
calf -induced C f + release. A fundamental property of RY receptors is that they can be both activated and inhibited by cytosolic Ca2+. ~a ' " at nanomolar to micromolar concentration increases the open probability of RY, receptor by acting on the high-affinity ca2+ -bindin sites. The concentration and speed of delivery of Cak' are critical determinants for activation of RY receptors (35) . Activation of L-type caLt channels at more negative potentials (e.g. -40 to -10) is more effective in activat,ing RY receptor because of larger driving force of ca2+ at more negative voltages. Brief opening of L-type caLt channels may be more effective in activating RY receptors than long-lasting opening. A micromolar to millimolar concentration of ca2+ decreases open probability of RY receptor by acting on the low-affinity cast-binding sites. ~g " + competes with ca2+ at both the activation and inhibition sites of RY receptors. RY receptor and redox states. The tetrameric RY, has -80 free cysteines, some of which are critical for gating the channel. Reduced glutathione inhibits, and oxidized glutathione activates RY receptors (38) . Redox-active molecules including NO and free radicals may thus aftect KY receptors, anti such processes are likely to be of physiological or pathological significance. Thiol oxidation has been shown t,o activate p-cell RY receptor (5), leading to release of c2+ from intracellular stores and increase of [ca2+],. (39) .
RY RECEPTOR PHARMACOLOGY
RY receptors have binding sites for many agents reflected in the huge size of these channels. Methylxanthines, imidazoles and in~idazolines, perchlorates, suramin, and volatile anesthetics activate RY receptor. Inhibitors of RY receptors include ruthenium red, procaine, tetracaine, ryanodine, dantrolene, and octanol. Some of these agents have additional concentration-dependent effects on other channels or pumps. On the other hand, drugs such as verapa~llil and D600, commonly used as blockers of L-type ca2+ channel, also inhibit KY receptors (40) . Familiarity with the usage and mechanism of actlon of these pharmacological tools is inlportant for RY receptor studies.
ca2+ release by methylxanthines, imidazoles, and imidazolines. RiIillimolar concentrations of methylxanthines activate RY receptors directly and may increase CAMP level indirectly, i.e., by inhibiting phosphodiesteraqes (PDEs). Caffeine is the 111ost commonly used RY receptor-activator in muscle and neuronal research. The methylxanthines extensively used in islet research are theophylline and 3-isobutyl-1-methylxantl~i~~e (IBMX). The effects of theophylline and caffeine as activators of RY receptors are highly conlparable (41) . Millirnolar concentrations of IBMX, commonly used as a PDE inhibitor, can activate RY receptors directly (42) . In this respect, the efficacies of 1.5 nlmoVl caffeine, theophylline, and IBMX may be almost equal (43) .
Many imidazoles and imidazolines activate RY receptors (44) . The imidazole ring is part of the xanthine structures and appears to be necessary for activating RY receptors (45) . CAMP has an imidazole moiety as part of its structure. Dibutyryl CAMP, a lipophilic analog of CAMP, when used at rnillimolar concentration can activate RY receptor directly by binding to the caffeine site (44) . Theophylline, IBMX, and imidazole release ~a " from intracelldar stores of p-cells (10, (46) (47) (48) . Ca" release from ER st,ores can be detected by measuring Ca2+-activated plasma membrane conductance. In glucose-primed islets, theophylline increases "Rb+ efflux (49, 50) and hyperpolarizes the p-cell membrane (50), suggesting ca2+ release from the ER and consequent activation of calcium-activated K+ channels (~+,a. This ca2+ release and consequent increased '%b+ eeBux cannot be entirely due to inhibition of PDEs. The structurally related activator of RY receptors, imidazole, which activates PDEs (51,52), also increases "~b + efflux (indicating ca2' release from ER) in glucoseprimed islels (53).
ca2+ release by caffeine. Compared with theophylline
and IBMX, fewer studies tested Ca2+ release by caffeine in p-cells. The main regulator of RY, receptor is ca2+, which activates or inhibits the channel, depending on concentration of the ion and the rate at which it is delivered. ~a " binds to separate high-afiity activation and low-afiity inhibition sites on the RY receptor. There is thus a conlpetition between the two, and it appears that activation can only take place if the increase in [ca2+],. is fast (35, 54) . The full-blown Ci2+ release by caffeine, as occurs in situ is a two-step process; in the first step, there is a small Ca2+ release by caffeine. If the released ca2+ is mopped up, for instance, by binding to high intracellular buffers or fura-2, the second step will not be engaged (54) . The second step is a regenerative phenomenon in which released Ca2+ acts on a cluster of RY receptors, triggering large c~' release. Caffeine increases the ~a ' + m i t y of the Ca2+ activation site of RY receptor. For caffeine to activate RY receptor optimally, it must increase the sensit,ivity of the activation site to Ca2+ quickly, so that there is little time for inhibition of the channel by the released Ca"+ (54). Slow application of caIfeine by conventional perfusion systems driven by peristaltic pumps may not elicit a rise in [Ca'"], (20) . Furthermore, when channel density is low, a modest ~a '~+ release by caffeine is counteracted by extrusion and uptake mechanisms (56) . Caffeine applied rapidly by a puffer pipette or a U-tube (56) typically induces transient increase in [ca2+], (16, 19, 29, (57) (58) (59) . Dose-response studies of cazf release by caffeine in p-cells have not been reported but the most commonly used concentration is 5-10 mmoV1. From studies in other cells, it is known that the threshold concentration of caffeine for ~a ' " release is -250 pmoM (43) .
When [ca2+], is measured in single p-cells, only -20-50% of cells respond to caffeine (16, 17, 58) . This suggests that several conditions must be fulfilled for activation of KY receptors. The number of cells responding to caffeine and magnitude of Ca2+ release is increased by various (ATP-sensitive potassium) channel and possibly by-activating a nonselective cation channel in the plasma, membrane (61) . The resulting ca2' entry through the plasma membrane Ca2+ channels may obscure caffeine-induced ca2+ release (20) . Experimentally such difficulties can be avoided if caffeine is used under conditions in which membrane potential is clamped at -70 mV (I!)). Other activators of RY receptors. 9-methyl-7-bromoeudistornin D is a novel activator of RY receptors (62) . It is useful since it is not a methylxanthine and does not inhibit PDEs. 4-chloro-m-cresol and Pchloro-3-ethylpheno1 are also useful since they do not inhibit PDEs, activate RY receptors, and do not activate IP,Rs (16, 22, 63, 64) . However, they inhibit islet metabolism (65) . (24) and (3-cells is inhibited (19) . If such protocols are not used and ryanodine is added to the perfu5ion for a brief period, the RY receptor of @cells may appear to be insensitive to the inhibitory action of the alkaloid (59, 64) . This may explain why some reports demonstrate clear effect of ryanodine on p-cells (19, 66, 67) , whereas others find little or no effect (2,3). It must be emphasized that it is often difficult to inhibit RY receptors by high concentration of ryanodine in intact cells and such lack of inhibition alone should not preclude conclusions as to the existence or involvement of RY receptors in intact cells (68) .
REGULATION OF RY RECEPTORS BY SECOND MESSENGERS
PKA-dependent and -independent effect of CAMP on CICR. CAMP is not primarily a ca2'-releasing messenger in the sense that inositol 1,4, (60) . PKA phosphorylation brings the RY, receptor to an excitable state: the channel can then be excited either by the ca2+ entering through the voltagegated ca2+ channels or simply by high loading of the ER (37). Furthermore, PKA phosphorylation favors dissociation of FKBP12.6 from RY, and thus increases open probability of the channel (31).
Kang et al. (26) have described a PKA-independent effect of CAMP on the RY receptor of P-cells. In this mode, CAMP promotes ca2+ release through RY receptor as a consequence of increased filling of the ER by a mechanism that involves CAMP-regulated guanine nucleotide exchange factor and its interaction with Raplb (26, 69) . There is no consensus as to the consequences of phosphorylation of IP,Rs in terms of ca2+ release. Xestospongic C, an inhibitor of IP,Rs, does not inhibit CICR in p-cells, suggesting that IP,Rs do not play a major role in mediating CICR in these cells (26) . Some reports indicate that phosphorylation of type 1 and type 3 IP,Rs decreases Ca2+ release (70, 71) . Detailed studies in p-cells suggest that, when CAMP releases Ca2' from ER, it is likely that the release is through RY receptor rather than through IP,Rs (19, 72) .
Modulation of RY receptors by nitric oxide.
In p-cells, nitric oxide (NO) releases ~a ' " from ER (17, 73) . There is evidence that this is due to activation of the RY receptors (17) . NO reversibly activates RY receptors by oxidation or by poly-S-nitrosylation (74) of critical thiols associated with the channel (5, 39, 75) . The effects of NO (and cGMPmediated phosphorylation) on IP,Rs are largely inhibitory (76) . Another pathway by which NO activates RY receptor is via cGMP, which in t u n activates ADP-ribosyl cyclase, leading to formation of cADPR (77) . This pathway is not involved in NO-induced ca2+ release in p-cells since specific inhibitors of cADPR do not block this release (57) . NO induced ca2+ release in P-cells has been implicated in exocytosis (1 7), synchronization of ca2 + signal (73) , and apoptosis (78) . Cyclic ADP-ribose. The NAD+ metabolite cADPR releases ca2+ through a RY receptor-like channel (79). cADPR, however, does not bind to RY receptor or FKBPs associated with the channel (32), and some investigators do not see any effect of cADPR on RY receptors (33) . In p-cells, cADPR releases ca2+ from the ER (18) , but this has not been a universal finding (12, 80, 81) . Inappropriate experimental conditions as well as low levels of RY receptors in some insulin-secreting cells may partly account for such differences. More recently, Mitchell et al. (22) and Varadi and Rutter (82) used techniques that are sensitive in detecting local CaL+ release from secretory vesicles and ER. Their data provide convincing evidence that micromolar cADPR releases ca2+ from both the secretory vesicles and ER of MIN6 cells. It is not clear whether this is due to specific interaction of cADPR with its channel or due to interaction of cADPR with the adenine-nucleotide binding site of the RY receptors (83) . In this regard, information on whether ca2+ release by cADPR could be inhibited by inhibitors, e.g., 7-deaza-8-bromo-cyclic ADP-ribose, would be useful. It is noteworthy that cADPR antagonists cannot inhibit ca2+ release through RY receptors of p-cells, suggesting that cADPR receptor may be different from RY receptors (57) . Nevertheless, these recent data, together with the fact that glucose increases cADPR in p-cells, should renew interest in search for the elusive cADPR receptor (18, 84) .
REGULATION OF RY RECEPTORS BY SIGNALS GENERATED FROM GLUCOSE METABOLISM
p-cells act as fuel sensors by virtue of having KATP channels (85) . However, the cells continue this function even under conditions in which KATp channels are clamped by diazoxide (86) . It is likely that ATP and some other molecules arising from nutrient metabolism act on other ion channels or exocytotic processes. Molecules that arise from nutrient metabolism and activate RY receptors include ATP, glycolytic intermediates, palmitoyl CoA, and cADPR. Moreover, a physiological alkaline shift of intracellular pH, such as that occurs on glucose stimulation, favors activation of the RY receptor (87) . In in vitro experiments, it is possible to demonstrate that glucose releases ca2+ from the ER, suggesting that some metabolites of glucose may favor activation of intracellular ca2+ channels (88) . ATP. ATP favors ~a " release through RY receptors by I) filling the ca2+ stores, 2) binding ~g~+ and thereby reducing cytosolic [~g " ] , and 3) allosteric regulation of RY receptor. In the presence of subactivating [ca2+], physiological levels of ATP directly activates RY, receptor by acting on the ATP-binding site, whereas ADP acts as a partial agonist (89) . In resting p-cells, high cytosolic [~g'"] keeps the RY receptor inhibited. Glucose stimulation reduces cytosolic [~g~+ ] by increasing ATP production and [ATP] (90) and thereby facilitates RY receptor activation. Glycolytic intermediates. Fructose 1,6-diphosphate (FDP), a product of the rate-limiting enzyme phosphofructokinase, activates RY, receptor and sensitizes the receptor to other activators (91, 92) . Consistent with this, FDP stimulates insulin secretion from HIT-TI5 cells (27,93). It should be noted that FDP and several other glycolytic intermediates inhibit binding of IP, to IP,Rs, thus making it unlikely that IP,Rs participate in this response (92) . Long-chain acyl CoA. Glucose metabolism increases level of cytosolic long-chain acyl CoA (94) . Such longchain acyl CoAs sensitize RY, receptors of p-cells (22) . Palmitoyl CoA sensitizes RY, receptors to activation by Ca2+ by mechanisms that include relief of ~g ' " inhibition of the channel. cADPR. Several groups have demonstrated acute increase of cADPR in glucose-stimulated p-cells (84, 95) , but this is not a universal observation (96) . Measurement of cADPR in p-cells seems to be technically difficult. Recent availability of a more convenient and sensitive method for cADPR measurement may be helpful in elucidating the signaling role of cADPR in p-cells (97) .
ROLE OF RY RECEPTORS IN MITOCHONDRIAL C A~+ SIGNALING
Mitochondrial ATP production is essential for stimulussecretion coupling in p-cells. AII increase in [ca2+], increases mitochondrial ca2+ concentration ([ca2+],) and enhances mitochondrial ATP production (98) . Because ER and mitochondria appear to be in close opposition, some RY receptors may be located close to the mitochondria. Studies in many cells have demonstrated a functional coupling between RY receptors and mitochondria. In p-cells, an important function of RY receptors may be to amplify ~a ' " signals by CICR to produce microdomains of high [~a"],, which would act as sources for elevating [ca2+], and thus accelerate ATP production.
ROLE OF RY RECEPTORS IN GLUCOSE-STIMULATED INSULIN SECRETION
The effects of ca2+ on cellular processes depend on the subcellular location of the [ca2+], increase. Furthermore, the integrity of the [ca2+], oscillatory process is important for secretion. caL+ release through RY receptor may affect secretion positively or negatively. By increasing [ca2+], near the secretory sites, it may trigger exocytotic fusion of the secretory granules with the plasma membrane. On the other hand, by increasing [ca2+ 1, near Kf , , channels, it can result in hyperpolarization of the p-cell membrane and inhibit secretion. Intermittent release of Ca2+ through RY receptor will have an intermittent hyperpolarizing effect, which may not inhibit net secretion and may rather increase it. Persistent release of Ca2+ will hyperpolarize for a prolonged period and will lead to inhibition of secretion. Whether ca2+ released through RY receptor is more readily available to the exocytotic sites or to the site of KtFT channels is not known. In adrenal chromaffin cells, Ca released through RY receptors is predominantly for driving the exocytotic processes (29, 99) . In p-cells, ca2+ released through the RY receptors appear to be available to the exocytotic sites for stimulating secretion (17) .
The role of RY receptors can be examined by testing the effects of methylxanthines. Because these tools have side effects, results need to be interpreted with careful reflection. By sensitizing RY receptors to incoming ca2+, methylxanthines enhance CICR. By this means and the consequent effect on K+,, channels, methylxanthines are expected to terminate a burst earlier and to shorten the duration of the slow waves. By affecting another group of K+ channels, i.e., inhibiting the KATp channels directly, methylxanthines shorten the interval between the slow waves. The net effect is an increase in the number of bursts per minute. Such effects on electrical activity of p-cells are seen when theophylline is applied to p-cells stimulated by glucose (50, 100) . Consistent with this, theophylline and caffeine markedly potentiate glucose-induced insulin secretion (101, 102) . At high concentrations, caffeine inhibits glucose transport (103) but still stimulates insulin secretion (20, 104, 105) . Stimulation of insulin secretion by caffeine and theophylline is tacitly assumed to be solely due to CAMP. However, an examination of the quantitative =pects of secretion by theophylline and CAMP suggests involvement of RY receptors. Thus, in rat islets, in ca2+-free medium and 16.7 mmoYl glucose, 1.4 mmol~l theophylline stimulates insulin secretion, which is three times more than that induced by 1 mmoyl dibutyryl CAMP (106) . Imidazole, which does not inhibit islet PDEs (51), but sei~sitizes RY receptors (44) , stimulates secretion (107) . Another way to dissect the RY receptor-activating and the PDE-inhibitory effect of methylxanthines is to use RY receptor inhibitors. In rat islets, tetracaine inhibits insulin secretion stimulated by theophylline (106) . It should be emphasized that RY, receptor can be sensitized by CAMP-dependent phosphorylation (60) as well as by direct binding of methylxanthines to the channel. In either case, the main trigger for activation of RY receptor is still the ca2+ that enters through the voltage-gated Ca" channels. Thus, despite reservations about nonspecific actions of these drugs, the available data strongly support a role for RY receptors in glucose-induced exocytosis of insulin.
There is now compelling evidence that CAMP-linked incretin hormones stimulate glucose-dependent insulin secretion by mechanisms that include CICR through RY receptors (19, 26, 66) . Secretion is a complex process requiring more than just an elevation of [Ca2+],. Since ca2+ released through RY receptor is available to both exocytotic sites and the K+,, channel sites, it is not surprising that both stimulation and inhibition of secretion have been reported with RY receptor ligands. The results depend on the experimental conditions used and it is often so that the experimental protocols employed do not mimic the physiological situation. Thus NO, which activates RY receptor, can stimulate (108) or inhibit (109) insulin secretion. Imidazole, an activator of RY receptors can stimulate (107) or inhibit (110) secretion. Dantrolene, an inhibitor of RY receptor, has also been shown to inhibit (1 11) or stimulate (1 12) glucose-induced insulin secretion.
PHYSIOLOGICAL ROLES OF RY RECEPTORS IN GLUCOSE-INDUCED STIMULUS-SECRETION COUPLING
Depolarization-induced [ca2+], increase in p-cells is not just due to ca2+ entry through the voltage-gated Ci2+ channels. There is evidence that this Ca2+ signal is modulated by CICR and uptake of ca2+ into ER (2, 3) . In patch clamp experiments, ca2+ entry through voltage-gated ~a " channels may be overestin~ated. Most voltage clamp experiments in @-cells are done in the presence of very high extracellular [Ca'"] and a highly buffered and altered cytosolic environment. In such experiments, unlimited extracellular space permits a large influx of ca2+ through the channel. The [ca2+], increase obtained on depolarization in human @-cells is usually not very high (-300 nmoV1) (88) . However, when conditions are created where incoming Ca2+ can trigger the RY receptors, a very large increase in [Ca2'], is seen (2, 19, 113) . It is possible that under physiological conditions, there is relatively small ca2+ ertt.ry through the voltage-gated ca2+ channels, which in t u n is amplified by CICR.
Even if one accepts that @-cells do not have large amounts of RY receptors, they may be important because of their large conductance and strategic location within the cell. Some RY receptors drain a nonmitochondrial ciS+ pool that does not utilize a thapsigargin-sensitive pump (,5). This Ci" pool may represent the secretory vesicles (22) . RY receptors located on secretory vesicles allow brief bout of ca2+ entry through voltage-gated Ci2+ channels to generate a wave of [~a"], changes, which is required in the early steps of exocytosis, e.g., vesicle transport to exocytotic sites (1 15) .
Another myth that has been propagated over the years is that glucose alone is the most important stimulus for insulin secretion. In fact, in the physiological range of excursion of glucose concentration, glucose is a rather poor stimulator of insulin secretion from pure j3-cells. This is because glucose per se is not very effective in engaging CICR, which can be engaged efficiently if the process is sensitized, for instance, by CAMP-linked hormones (116) . It needs to be emphasized that CICR is a multistep process that is facilitated by many factors (2, 26) . RY receptors, together with the ER-associated ca2+ apparatus, act as a functional unit for co-incidence detection. A critical feature of RY receptor is that its gating is context-dependent (Fig. 1) 
RELEVANCE TO DIABETES
From studies in various animal models of type 2 diabetes, it appears that impairment of mechanisms that ensure optimal secretory response of p-cells is an important component in the pathogenesis of type 2 diabetes (118) . Impaired function of intracellular Ca2+ pools of p-cells has been described in several rodent models of type 2 diabetes (4, 119) . From the evidence discussed above, it seems fair to speculate that RY receptor-mediated CICR may be one of the many mechanisms that normally amplify insulin secretion following a trigger by nutrients (86) . Impaired glucose metabolism in p-cells will fail to trigger insulin secretion because of impaired ATP production. At the same time, such impairment may also impair CICR because of impaired production of molecules such as FDP, long-chain acyl CoA, cADPR, CAMP, etc.-molecules that normally sensitize the RY receptors. One of the mechanisms utilized by CAMP-linked incretin hormones to amplify insulin secretion is clearly the RY receptor-mediated CICR, and such hormones are potential antidiabetic drugs (19) . RY receptor may be relevant to the pathogenesis of type 1 diabetes also since this channel is a prototypic redox-sensitive ca2+ channel and may thus mediate damaging actions of NO and free radicals (78) .
CONCLUSION
The existence of RY receptors in p-cells is well documented. Any controversies about RY receptors of p-cells, including those involving cADPR, may be intrinsic to the complex mode of regulation of these channels and di&-culties associated with the usage of the pharmacological tools. One example of this is the distinct context-dependence of activation of RY receptors. Despite its low abundance, RY receptors of P-cells may play important roles in stimulus-secretion coupling by virtue of their strategic locations within the cell, their ability to mediate CICR in a context-dependent manner, and their large conductance. Being caz+-activated ion channels, RY receptors have the unique ability to interact with neighboring ca2+ channels and thereby amplify Ca2+ signals. Such amplification is engaged when the channel is sensitized by a set of messenger molecules generated from nutrient metabolism or ligand-binding. RY receptors are thus suitable for integration of signaling, co-incidence detection, and context-dependent signaling for insulin secretion. Secretagogues may modulate insulin secretion by affecting CICR mediated by RY receptor. Such processes may be involved in amplification of insulin secretion and may be a target for development of therapeutic agents that p-cells possess a robust mechanism For amplification of ca2+ signaling may advance our understanding of stimulussecretion coupling. Rigorous attention to experimental protocols, a clear understanding of the mechanism of action of RY receptor ligands as well as context-dependence of activation of these channels will help reduce controversies and move the field forward. Nevertheless, the issues involved need to be critically examined. Finally, the role of RY receptor-mediated CICR as a general mechanism for amplification of insulin secretion and factors that affect this process need to be explored.
